#United States #Fort Wayne #diabetes management #Glytec #Parkview Health

A New Era in Diabetes Management

In a significant move toward enhancing healthcare services, Glytec, recognized as a leader in AI-powered diabetes and glycemic management, has announced an expanded partnership with Parkview Health. This not-for-profit health system operates in northeast Indiana and northwest Ohio, and together, they aim to improve patient safety, clinical outcomes, and operational efficiencies across their network of facilities.

Partnership Expansion

The partnership focuses on renewing services across 10 facilities, implementing an Emergency Department integration, and extending its operations to two additional hospitals. This expansion aligns with Parkview Health's commitment to adapt to the latest standards set by the Centers for Medicare & Medicaid Services (CMS), particularly concerning electronic clinical quality measures (eCQMs) that relate to severe hypoglycemia and hyperglycemia, set to take effect on January 1, 2026.

Glytec first introduced its Glucommander® insulin titration software to the Parkview network, which integrates into Electronic Health Records (EHRs). This software is pivotal for diabetes and glycemic management, currently utilized by over 400 hospitals nationwide.

Addressing CMS Quality Mandates

With increasing pressure from CMS for hospitals to report eCQMs related to inpatient glycemic control, the partnership positions Parkview Health to effectively leverage technology that enhances care quality. Glytec's platform offers:
- Real-time clinical decision support: This feature aids in both IV and subcutaneous insulin dosing, ensuring that healthcare providers can make informed decisions based on real-time data.
- Automated alerts: These alerts notify clinicians of glucose fluctuations, which help them respond proactively to patient needs.
- Advanced analytics tools: These tools allow for tracking key quality indicators such as patient-days in range and avoided adverse events. They also provide insights into financial outcomes, helping to assess the return on investment (ROI) while ensuring compliance with CMS mandates.

Patrick Cua, CEO of Glytec, stated, "Our collaboration with Parkview Health highlights our shared objective: to enable safe, standardized, and measurable improvements in patient outcomes related to glycemic management. The expanded partnership allows Parkview to implement our leading software solution across its network, paving the way for compliance with CMS requirements and long-term health success for the community."

Proven Results

The effectiveness of Glytec's platform is backed by numerous studies and clinical evidence. Having been endorsed by over 100 clinical publications and holding over 100 patents, the platform has demonstrated its ability to:
- Reduce severe hypoglycemia events by as much as 99.8%.
- Decrease hospital length of stay and readmission rates.
- Achieve a return on investment of 6 to 8 times the initial expenditure.

Parkview Health will utilize this comprehensive platform to monitor quality metrics in real-time and analyze treatment outcomes at both existing and new hospital sites. It also equips clinical leaders with benchmarking tools, facilitates automated audits, and streamlines reporting relevant to CMS obligations.

About Glytec

Glytec's platform, renowned for its AI-driven technology, empowers healthcare providers to collaboratively manage diabetes and optimize insulin dosing. It is dedicated to improving patient care from hospital to home. The flagship solution, Glucommander®, integrates seamlessly with EHRs and offers clinical decision support and extensive analytics.

About Parkview Health

Established to serve the community, Parkview Health comprises over 15 hospitals and employs more than 16,000 staff members across various specialties. Its commitment to healthcare extends to advanced technology and innovation, emphasizing quality care for all patients, regardless of their financial situations. By reinvesting profits into community improvements, Parkview Health continues to enhance healthcare access and services for its patients.

In conclusion, the partnership between Glytec and Parkview Health marks a promising step forward in the realm of diabetes and glycemic management, aimed at improving patient outcomes and setting a higher standard of care in the Midwest.